Skip to main content
TipRanks
Go Ultimate75% OFF

Elevance Health (A58) Stock Price & Analysis

1 Followers

A58 Stock Chart & Stats

CHF 369.86CHF 0.00(0.00%)
At close: 5:30 PM GMT+1
No data to display
Day’s Range
CHF 369.86 - CHF 369.86
52-Week Range
CHF 346.20 - CHF 369.86
Previous Close
CHF 369.86
Volume
N/A
Average Volume (3M)
1
Market Cap
CHF 70.85B
Enterprise Value
CHF 115.48B
Total Cash (Recent Filing)
CHF 37.85B
Total Debt (Recent Filing)
CHF 30.76B
Price to Earnings (P/E)
16.8
Beta
-0.34
Next Earnings
Jan 27, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
1.48%

Bulls Say, Bears Say

Bulls Say

Strong Cash Generation

Elevance’s strong cash conversion provides internal funding for investments, capital returns, and balance-sheet needs. The $6.5 billion TTM free-cash-flow recovery indicates substantial earnings support, although continued monitoring is warranted because cash conversion has varied across years.

Carelon Growth Platform

Carelon broadens Elevance beyond traditional insurance risk through healthcare services sold to affiliated and external customers. New wins, high retention, and a broad pipeline can diversify revenue, deepen customer relationships, and support longer-term operating leverage.

Large Membership Scale

A membership base of nearly 45 million creates scale across networks, claims administration, pharmacy, and care-management capabilities. Commercial fee-based growth also supports revenue diversification while reducing reliance on any single government-sponsored membership category.

Bears Say

Margin Compression

Persistent margin compression reduces the earnings benefit of revenue growth and leaves less room for adverse medical-cost or pricing developments. Lower operating profitability also makes execution in Medicaid, Medicare Advantage, and commercial products more important to sustained returns.

Elevated Medical Cost Trends

When reimbursement rates lag underlying care costs, health-plan margins can remain pressured even when membership and premium revenue grow. Elevance expects improvement, but the timing depends on rate alignment and successful medical-cost actions across affected businesses.

Moderate-to-Elevated Leverage

Moderate-to-elevated leverage can constrain financial flexibility when operating margins are under pressure. It may limit the capacity to absorb weaker underwriting results or pursue investments while also increasing the importance of maintaining strong, predictable cash generation.

Elevance Health News

A58 FAQ

What was Elevance Health’s price range in the past 12 months?
Elevance Health lowest stock price was CHF346.20 and its highest was CHF369.86 in the past 12 months.
What is Elevance Health’s market cap?
Elevance Health’s market cap is CHF70.85B.
When is Elevance Health’s upcoming earnings report date?
Elevance Health’s next earnings report is estimated for Jan 27, 2027 (not yet confirmed), which is in 67 days.
How were Elevance Health’s earnings last quarter?
Elevance Health released its earnings results on Oct 21, 2026. The company reported CHF5.894 earnings per share for the quarter, beating the consensus estimate of CHF3.975 by CHF1.919.
Is Elevance Health overvalued?
According to Wall Street analysts Elevance Health’s price is currently Undervalued.
Does Elevance Health pay dividends?
Elevance Health does not currently pay dividends.
What is Elevance Health’s EPS estimate?
Elevance Health’s EPS estimate is 1.76.
How many shares outstanding does Elevance Health have?
Elevance Health has 216,055,900 shares outstanding.
What happened to Elevance Health’s price movement after its last earnings report?
Elevance Health reported an EPS of CHF5.894 in its last earnings report, beating expectations of CHF3.975. Following the earnings report the stock price went same ―.
Which hedge fund is a major shareholder of Elevance Health?
Hedge funds hold Elevance Health shares: the largest hedge-fund position in Elevance Health is 1,763,496,270 shares, and hedge funds decreased their holdings by 254.5K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology